6'-subsituted aminoyl benzimidazole-5-substituted methylindole derivative
A technology of carbamoyl benzimidazole and methyl indole derivatives, which is applied in the field of chemical drugs and their preparation and application, and can solve the problems of not being very significant
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] 2-{5-{[2-Ethyl-4-methyl-6-(N-benzylcarbamoyl)-1H-benzimidazol-1-yl]methyl}-1H-indol-1-yl } The preparation of benzoic acid (compound If):
[0048]
[0049] Dissolve N-benzyl-4-methyl-2-ethyl-1H-benzo[d]imidazole-6-carboxamide (compound c, 349 mg, 1.20 mmol) in 20 mL N,N-dimethylformamide Add sodium hydrogen (86.4mg, 3.6mmol) and stir at room temperature for 30min. Slowly add N-methoxycarbonylphenyl-5-bromomethylindole (compound III, 453 mg, 1.32 mmol) in N,N-dimethylformamide solution (10 mL) dropwise. After the dropwise addition was completed, the mixture was stirred and reacted at room temperature for about 2 h, and the reaction was monitored by TLC until the reaction was complete. 2 mL of 2M sodium hydroxide solution was added, and the reaction was stirred at room temperature for about 2 h. After the reaction is complete, adjust the pH value to 5-6 with 2M dilute hydrochloric acid, add 200 mL of dichloromethane and 200 mL of water to the reaction solution, and t...
Embodiment 2
[0052] 2-{5-{[2-Methyl-4-methyl-6-(N-benzylcarbamoyl)-1H-benzimidazol-1-yl]methyl}-1H-indole-1 The preparation of -yl}benzoic acid (compound Ia):
[0053] The preparation method is as described in Example 1.
[0054] 1 HNMR (400MHz, CDCl 3 ,ppm)δ8.05(d,J=7.7Hz,1H),7.66-7.60(m,1H),7.59-7.49(m,2H),7.46(d,J=6.4Hz,2H),7.32(d ,J=11.8Hz,6H),7.10(d,J=8.3Hz,1H),6.97(s,1H),6.91-6.88(m,1H),6.48(s,1H),6.37(d,J= 7.0Hz, 1H), 5.56(s, 2H), 2.88(q, J=7.6Hz, 2H), 2.57(s, 3H), 1.28(t, J=7.5Hz, 3H). 13 C NMR (101MHz, CDCl 3 ,ppm)δ169.35,168.58,158.63,137.91,137.84,137.54,134.80,131.74,131.16,130.17,128.80,128.70,128.70,128.63,128.19,128.13,128.01,127.91,127.91,127.56,127.38,126.37,126.24,122.32 ,120.99,117.13,110.36,108.33,99.78,45.72,16.89,12.54.MS(ESI)m / z:529.19[M+H] + .
Embodiment 3
[0056] 2-{5-{[2-Ethyl-4-methyl-6-(N-benzylcarbamoyl)-1H-benzimidazol-1-yl]methyl}-1H-indole-1 The preparation of -yl}benzoic acid (compound Ib):
[0057] The preparation method is as described in Example 1.
[0058] 1 HNMR (400MHz, CDCl 3 ,ppm)δ8.05(d,J=7.7Hz,1H),7.66-7.60(m,1H),7.59-7.49(m,2H),7.46(d,J=6.4Hz,2H),7.32(d ,J=11.8Hz,6H),7.10(d,J=8.3Hz,1H),6.97(s,1H),6.91-6.88(m,1H),6.48(s,1H),6.37(d,J= 7.0Hz, 1H), 5.56(s, 2H), 2.88(q, J=7.6Hz, 2H), 2.57(s, 3H), 1.28(t, J=7.5Hz, 3H). 13 C NMR (101MHz, CDCl 3 ,ppm)δ169.35,168.58,158.63,137.91,137.84,137.54,134.80,131.74,131.16,130.17,128.80,128.70,128.70,128.63,128.19,128.13,128.01,127.91,127.91,127.56,127.38,126.37,126.24,122.32 ,120.99,117.13,110.36,108.33,99.78,45.72,22.15,16.89,12.54.MS(ESI)m / z:534.24[M+H] + .
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


